Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti-cancer agents in the adjuvant setting

Postoperative adjuvant chemotherapy for patients with stage III colon cancer (CC) is regarded as the standard treatment worldwide for outcome improvement and relapse prevention. Similarly, high-risk stage II CC requires adjuvant chemotherapy because of its high recurrence rate. Previous randomized c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Clin Oncol
Päätekijät: Mizuuchi, Yusuke, Tanabe, Yoshitaka, Sada, Masafumi, Kitaura, Yoshiki, Nagai, Shuntaro, Watanabe, Yusuke, Tamiya, Sadafumi, Nagayoshi, Kinuko, Ohuchida, Kenoki, Nakano, Toru, Nakamura, Masafumi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2021
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082226/
https://ncbi.nlm.nih.gov/pubmed/33936595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2021.2284
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia